Presenter's Information

Soo-Jin Kang, MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. Machine Learning-Based Models for Interpreting IVUS
  2. Low FFR But Normal Thallium: How to Evaluate, Interpret and Treat It?
  3. IVUS: Pre- and Post-Intervention
  4. [Review in 2015] Imaging
  5. Visual-Functional Mismatch: FFR, Not CAG, Has Prognostic Value!!
  6. Clinical Impact of Neoatherosclerosis
  7. Vulnerable Plaques: Natural History and Clinical Outcomes
  8. Vulnerable Plaque Detection by VH-IVUS
  9. Visual-Functional Mismatch: Anatomy vs. Function
  10. Intravascular Imaging Assessment of Late Stent Failure
  11. Cross-over Technique: When and How to Do & Clinical Outcomes
  12. Neoatherosclerosis in New DES: Insight from Intracoronary Imaging
  13. Statin Treatment Can Stabilize Coronary Plaque Vulnerability: A Double-Blind, Randomized Study
  14. Then, How to Define Vulnerable Plaque?
  15. VH IVUS: Native Plaque and Neointima
  16. Update - Clinical Implication of Neoatherosclerosis
  17. IVUS MLA Criteria and FFR: Left Main and Non-Left Main
  18. How to Physiologically Interpret IVUS Parameters?
  19. iFRFrom FFR to iFR
  20. Clinical Implementation of IVUS
  21. How to Utilize Invasive Imaging in LM PCI
  22. Step-by-step Approach for Complex Bifurcations Using Angiography, IVUS and FFR
  23. Ischemia Mapping: FFR in Bifurcation Lesions
  24. [Does Morphology Predict Future Events?] Con: No, It Is Not Enough
  25. Main Mechanism of DES ISR: Underexpension, Intimal Hyperplasia, Neoatheroscrelosis, Stent Fracture and Malapposition
  26. Carina Shift vs. Plaque Shift: Prevalence and Implication
  27. In-stent Neoartherosclerosis: A Final Common Pathway of Late Stent Failure
  28. Plaque Shift vs. Carina Shift: Identification and Clinical Impact
  29. IVUS-MLA Criteria Matched with FFR<0.8
  30. How to Utilize IVUS in Bifurcation Stenting
  31. Very Late Stent Thrombosis After DES Implantation
  32. How to Integrate the Morphology and Function of Non-LM Bifurcation
  33. Invasive Functional Assessment of LM: IVUS and FFR
  34. Usefulness of OCT in Ambiguous Lesion
  35. VH and OCT Characteristics of Neoatherosclerosis: A Mechanism of Late Stent Failure
  36. FFR-guided Decision and IVUS-guided Optimization in LM PCI
  37. Tissue Characterization of Neointima by IVUS,VH, OCT
  38. IVUS-FFR: Optimal Cut-off of MLA
  39. Insights from FFR and IVUS for Bifurcation PCI
  40. Long-Term OCT and VH-IVUS Follow-Up of BMS and DES: Neoatherosclerosis of In-Stent Neointima
  41. Pre- and Post- Stenitng IVUS Assessment of LM Bifurcation
  42. IVUS-Guided Provisional Stenting: Plaque or Carina Shift
  43. Tissue Characterization of Neointima by VH, OCT
  44. Assessment of In-Stent Restenosis Using Gray-Scale IVUS, IVUS-VH and OCT
  45. IVUS Evaluation for the Site of Bifurcation After Cross-Over Stenting
  46. DES Fracture Caused by Coronary Aneurysm and Malapposition
Conference Slides
Category